132 related articles for article (PubMed ID: 17574455)
1. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.
Evans J; Powell JT; Schwalbe E; Loftus IM; Thompson MM
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):302-3. PubMed ID: 17574455
[TBL] [Abstract][Full Text] [Related]
2. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.
Hurks R; Hoefer IE; Vink A; Pasterkamp G; Schoneveld A; Kerver M; de Vries JP; Tangelder MJ; Moll FL
Eur J Vasc Endovasc Surg; 2010 May; 39(5):569-76. PubMed ID: 20226696
[TBL] [Abstract][Full Text] [Related]
3. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm.
Grzela T; Brawura-Biskupski-Samaha R; Jelenska MM; Szmidt J
Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):159-61. PubMed ID: 17964826
[TBL] [Abstract][Full Text] [Related]
6. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture.
Petersen E; Gineitis A; Wågberg F; Angquist KA
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):457-61. PubMed ID: 11112465
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.
Piechota-Polanczyk A; Demyanets S; Mittlboeck M; Hofmann M; Domenig CM; Neumayer C; Wojta J; Klinger M; Nanobachvili J; Huk I
Eur J Vasc Endovasc Surg; 2015 May; 49(5):549-55. PubMed ID: 25800096
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells.
Lindeman JH; Abdul-Hussien H; van Bockel JH; Wolterbeek R; Kleemann R
Circulation; 2009 Apr; 119(16):2209-16. PubMed ID: 19364980
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
Wilson WR; Evans J; Bell PR; Thompson MM
Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):259-62. PubMed ID: 16009575
[TBL] [Abstract][Full Text] [Related]
10. Measure what matters: institutional outcome data are superior to the use of surrogate markers to define "center of excellence" for abdominal aortic aneurysm repair.
Goshima KR; Mills JL; Awari K; Pike SL; Hughes JD
Ann Vasc Surg; 2008; 22(3):328-34. PubMed ID: 18411029
[TBL] [Abstract][Full Text] [Related]
11. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.
Mastoraki ST; Toumpoulis IK; Anagnostopoulos CE; Tiniakos D; Papalois A; Chamogeorgakis TP; Angouras DC; Rokkas CK
Ann Vasc Surg; 2012 Feb; 26(2):250-8. PubMed ID: 22222170
[TBL] [Abstract][Full Text] [Related]
12. Medical management of abdominal aortic aneurysm.
Golledge J; Powell JT
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):267-73. PubMed ID: 17540588
[TBL] [Abstract][Full Text] [Related]
13. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms.
Abisi S; Burnand KG; Humphries J; Waltham M; Taylor P; Smith A
Br J Surg; 2008 Mar; 95(3):333-7. PubMed ID: 17968978
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target.
Sinha S; Frishman WH
J Clin Pharmacol; 1998 Dec; 38(12):1077-88. PubMed ID: 11301559
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture.
Wilson WR; Anderton M; Schwalbe EC; Jones JL; Furness PN; Bell PR; Thompson MM
Circulation; 2006 Jan; 113(3):438-45. PubMed ID: 16432074
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter.
Papalambros E; Sigala F; Georgopoulos S; Menekakos C; Giatromanolaki A; Bastounis E; Sivridis E
Int J Mol Med; 2003 Dec; 12(6):965-8. PubMed ID: 14612975
[TBL] [Abstract][Full Text] [Related]
17. Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm.
Piechota-Polanczyk A; Demyanets S; Nykonenko O; Huk I; Mittlboeck M; Domenig CM; Neumayer C; Wojta J; Nanobachvili J; Klinger M
Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):682-8. PubMed ID: 23558220
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms.
Schweitzer M; Mitmaker B; Obrand D; Sheiner N; Abraham C; Dostanic S; Meilleur M; Sugahara T; Chalifour LE
Vasc Endovascular Surg; 2010 Feb; 44(2):116-22. PubMed ID: 20034937
[TBL] [Abstract][Full Text] [Related]
19. Cysteine protease activity in the wall of abdominal aortic aneurysms.
Abisi S; Burnand KG; Waltham M; Humphries J; Taylor PR; Smith A
J Vasc Surg; 2007 Dec; 46(6):1260-6. PubMed ID: 18155003
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin suppresses experimental aortic aneurysm expansion.
Kalyanasundaram A; Elmore JR; Manazer JR; Golden A; Franklin DP; Galt SW; Zakhary EM; Carey DJ
J Vasc Surg; 2006 Jan; 43(1):117-24. PubMed ID: 16414398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
